This analysis demonstrated that prevention of adherence to activated ECs significantly decreased the numbers of viable leukemia cells remaining following Ara-C treatment in comparison to cultures without anti-E-selectin treatment (Figure 4E). The gene discussed is SELE; the disease is leukemia.